Supplementary Materials and Methods Isolation of mouse intestinal epithelial cells and blood mononuclear leukocytes (ML). Mouse colonic segments were excised and flushed with ice-cold phosphate-buffered saline (PBS) for the isolation of epithelial cells, as described previously (1-3). Segments were inverted on an iron rod (diameter ~3 mm) and then were immersed in PBS with 5.56 mM glucose (PBS-G) containing 0.5 mM dithioerythritol (DTT) for 30 min. The inverted intestines then were placed in PBS-G containing 30 mM EDTA for 20–30 min at 37°C with gentle shaking every 5 min. Epithelial cell purification was achieved by passing the cell suspension through a mesh filter with a pore size of 40 μm. The cells on the mesh were collected by eluting the inverted filter with PBS-G containing 1mM EDTA. Cells then were washed again with PBS-G. The viability and purity of colonocytes were determined in a pilot study that confirmed trypan blue-negativity (91.7 0.6%), BerEP4 (an epithelial marker)-positivity (91.1 1.2%), and the absence of CD68 (a monocyte/macrophage marker) transcripts in the cell preparation. Isolated cells were subjected to RNA extraction for RT-PCR analysis of CD14, TLR4, and MD2 mRNA. Heparinized mouse blood was overlaid onto an equal volume of Histopaque 1083, and samples were centrifuged at 400 g for 30 min without brake. After removing the upper plasma layer, cells at the interface were collected into a fresh tube and washed three times in ice-cold PBS. Pelleted blood cells (mononuclear leukocytes) were used for as a positive control in RT-PCR analysis of CD14, TLR4, and MD2 mRNA. Reverse transcription-polymerase chain reaction (RT-PCR) Total RNA was extracted from samples using Trizol reagent (Life Technologies) according to the manufacturer’s instructions. The RNA (2 μg) was reverse transcribed with oligo(dT)15 using RevertAid™ First Strant cDNA Synthesis kit (Thermo) in 20 μL reaction volume. The resulting cDNA corresponding to 0.1 µg of initial RNA was then subjected to PCR by the addition of master mix containing 1X PCR buffer, 1 U DreamTaq™ DNA Polymerase, 0.2 mM dNTPs mixture, 0.4 μM upstream primer, and 0.4 μM downstream primer. The specific primer pairs for PCR reaction were as follows: human CD14 (forward, 5’-CTGCAACTTCTCCGAACCTC-3’ and reverse, 5’-CCAGTAGCTGAGCAGGAACC-3’), 5’-TGAGCAGTCGTGCTGGTATC-3’ human MD2 human and (forward, mouse CD14 (forward, human and reverse, (forward, 5’-CAGGGCTTTTCTGAGTCGTC-3’), 5’-ATTGGGTCTGCAACTCATCC-3’ 5’-CGCTTTGGAAGATTCATGGT-3’), 5’-CCAAGAGCCTCCAGTAGACG-3’ reverse, TLR4 and PKCζ reverse, (forward, 5’-CCATCCATCCCATCGATAAC-3’), 5’-GTCAGGAACTCTGGCTTTGC-3’ and reverse, 5’-TGGCTTTTACCCACTGAACC-3’), mouse TLR4 (forward, 5’-TGGCATCATCTTCATTGTCC-3’ and reverse, 5’-CGAGGCTTTTCCATCCAATA-3’), mouse MD2 (forward, 5’-CTTTTCGACGCTGCTTTCTC-3’ 5’-ATCCATTGGTTCCCCTCAGT-3’), mouse 5’-CACCAGCTTACCCCATGACT-3’ mouse CD68 (forward, and reverse, and Lgr5 reverse, (forward, 5’-CTCCTGCTCTAAGGCACCAC-3’), 5’-TTCTGCTGTGGAAATGCAAG-3’ and reverse, 5’-AGAGGGGCTGGTAGGTTGAT-3’), β-actin (forward, 5’-GGGAAATCGTGCGTGAC-3’ and reverse, 5’-CAAGAAGGAAGGCTGGAA-3’). All of the primer pairs were designed based on the sequences reported in NCBI nucleotide database. The DNA thermal cycler was programmed to perform a protocol as follows: 95°C for 3 min for 1 cycle; 95°C for 30 sec (denaturation), 55°C for 30 sec (annealing), and 72°C for 30 sec (extension) for 30 cycles; and 72°C for 7 min for final extension. Negative controls were performed with samples lacking cDNA that was not reverse transcribed. RT-PCR products were then electrophoresed in a 1% agarose gel in the presence of 0.5 μg/mL ethidium bromide, visualized with an ultraviolet transilluminator, and photographs were taken. The intensity of the DNA bands was analyzed using the Gel-Pro Analyzer 4.0 software (4). Histopathological examination. Intestinal tissues were fixed in 4% PFA and embedded in paraffin wax with proper orientation of the crypt to villus axis before sectioning. Sections of 5 μm thickness were deparaffinized with xylene and graded ethanol, stained with haematoxylin and eosin (H&E), and observed under a light microscope (1, 5). Immunofluorescent staining and confocal microscopy. The intestinal tissues or cell monolayers were processed for immunofluorescent staining as previously described (1, 3, 4). Briefly, intestinal samples are fixed with 4% PFA for 1 h on ice, followed by OCT solution for 1 h and snap frozen in liquid nitrogen. Tissue sections were quenched with 50 mM NH4Cl in PBS for 10 min at room temperature. The cells on filter supports were fixed with 4% PFA, permeabilized with 0.5% Triton X-100 and quenched with 50 mM NH4Cl. After blocking with 1% BSA, tissue and cells were stained with primary antibodies to CD14, TLR4, or MD2, followed by secondary antibodies. The cell nuclei were stained with Hoechst dye. The filter support was cut off and mounted on slides, and images were captured using a fluorescent microscope or a laser-scanning confocal microscope (Zeiss LSM780, Germany). Western blotting. Intestinal mucosal proteins were extracted with complete radio-immunoprecipitation (RIPA) buffer and subjected to SDS/polyacrylamide gel electrophoresis (PAGE) (4–13% polyacrylamide) as described (2, 5). The resolved proteins were then electrotransferred onto PVDF membranes. Blots were blocked with 5% (w/v) nonfat dry milk or 5% (w/v) bovine serum albumin in Tris-buffered saline (TBS) containing 0.1% (v/v) Tween 20 (TBS-T) for 1 h, washed with TBS-T, and incubated with a primary antibody at 4°C overnight. The membrane was washed and incubated with a secondary antibody for 1 h. After washing, the membranes were incubated with chemiluminescent solution and signals detected. Enzyme-linked immunosorbent assay (ELISA). Mouse blood samples were collected by intracardiac puncture. The levels of Tumor Necrosis Factor (TNF)-alpha (Peprotech) and Keratinocyte Chemoattractant (KC; murine analog of IL-8) (R&D systems) were measured using ELISA development kits according to the manufacturer's instructions. Quantification of mucosa-associated LPS levels. To measure mucosal LPS levels, scraped colonic mucosa were homogenized in 99 volumes of pyrogen-free distilled water and were centrifuged at 3,000 rpm for 15 min. The resultant supernatants were eluted through nitrocellulose filters (0.45 μm pore size) and were applied to chromogenic Limulus amoebocyte lysate (LAL) tests using an Endotoxin Quantitation kit (Thermo Scientific, Rockford, IL, USA), according to the manufacturer’s instructions. The amount of p-Nitroaniline released by endotoxin-activated LAL enzyme was measured in a spectrophotometer at 405 nm after diazotization. Cell lines. Human CRC Caco-2 and HT29 cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) (Life Technologies) (4, 6, 7). T84 cells were grown in DMEM/Nutrient Mixture F-12 Ham (DMEM/F-12) (Sigma). The medium was supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 0.1 mg/ml streptomycin (Sigma). Human holo-transferrin (11 mg/l; Sigma) and HEPES (15 mM) were added to the medium for Caco-2 cell culture. Cells were grown to confluence at 37°C with 5% CO2 in a humidified incubator for experiments. Mouse leukemic monocyte/macrophage RAW264.7 cells and human promonocytic THP-1 cells were grown in RPMI 1640 (Life Technologies) supplemented with 10% FBS, 10 mM HEPES, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. The culture medium for RAW264.7 cells contained 0.05 mM 2-mercaptoethanol (Life Technologies). Culture medium was replenished every 2–3 d. Differentiation of THP-1 cells was induced by treating with 100 ng/ml phorbol 12-myristate 13-acetate (Sigma) for 2 d on culture plates at a concentration of 5106 cells/well. Cells were grown to confluence at 37°C with 5% CO2 in a humidified incubator for experiments. Lipid extraction and ultra-performance liquid chromatography (UPLC)-tandem mass spectrometry (UPLC-MS/MS). Cells were harvested for lipid extraction as previously described with some modifications (8). Caco-2 cells (3×105 cells) resuspended in 800 μl PBS were mixed with 90 μl of internal standard (C6 ceramide; 90 μl of 1 μg/ml ethanolic solution) and 3 ml of chloroform/methanol (1:2, v/v), vortexed for 30 s, and incubated overnight at 4°C. After adding 1 ml chloroform and 1 ml PBS, mixtures were centrifuged at 2,000 g for 10 min for phase separation. The organic layer was obtained and evaporated to dryness under nitrogen gas. The dried residue was dissolved in 100 μl of mobile phase solution (acetonitrile:ammonium formate = 1:1, v/v). UPLC-MS/MS was performed using an Acquity UPLC system (Waters, Milford, MA, USA) coupled with a Quatro Micro triple-quadrupole mass spectrometer (Micromass, Manchester, UK) equipped with an electrospray ionization source. The mass spectrometer was operated in the positive ion electrospray mode with selective reaction monitoring. Analyses were performed in positive mode with a cone voltage of 20 V for AA I and 20 V for AA II, an extractor voltage of 3.0 V, an RF lens voltage of 0.0 V, a capillary voltage of 3.0 kV, an ion source temperature of 80°C, and a desolvation temperature of 450°C. A cone gas flow of 50 L/h and a desolvation gas flow of 1100 L/h were used. Argon (99.99%) was used as a collision gas. The gas flow rate was kept at 0.13 nl/min in the collision cell. The collision energy was 12 eV for AA I and 10 eV for AA II. MassLynx 4.1 software was used for data analysis. Chromatographic separation was performed using an Acquity BEH C18 column (100 mm × 2.1 mm, 1.7 μm) (Waters). The mobile phase was composed of 5 mM ammonium formate (pH 4.0) (solvent A) and acetonitrile (solvent B). The gradient profile was as follows: 0–2 min: linear from 50% to 90% B; 2–16 min: linear from 90% to 100% B; 16–20 min: 100% B; 20–20.1 min: linear from 100% to 50% B; 20.1–23 min: 50% B then re-equilibration of the column. The flow rate was kept at 0.3 ml/min. The column oven was set at 40°C, and the auto-injection system was set at 4°C. A partial loop with needle overfill mode was used for sample injection, and the injection volume was 5 μl. Plasmid constructs and point mutation. The expression vector pMyc-CMV1-huTLR4 was kindly provided by Dr. Douglas T. Golenbock (University of Massachusetts Medical School, Worcester, MA, USA). The coding sequences of all plasmid constructs were confirmed by automated sequencing analysis. Point mutations were created by site-directed mutagenesis using KAPA HiFi PCR kits (Kapa Biosystems, Woburn, MA, USA), according to the manufacturer’s instructions. The following primer pairs were used for Asp299Gly mutation (D299G) (nucleotide change, A896G): forward (5’-ttagactactacctcgatgGtattattgacttattt-3’) (5’-aaataagtcaataataCcatcgaggtagtagtctaa-3’); (nucleotide change, and for reverse Thr399Ile C1196T): mutation (T399I) forward ctgttctcaaagtgattttgggacaaTcagcctaaagtatttagatctgagc-3’) and (5’reverse (5’-gctcagatctaaatactttaggctgAttgtcccaaaatcactttgagaacag-3’); and for Pro714His mutation (P714H) (nucleotide (5’-ctacagagactttattcAcggtgtggccattgctgc-3’) change, C2141A): and forward reverse (5’-gcagcaatggccacaccgTgaataaagtctctgtag-3’). Nucleotide changes are shown in uppercase. Cells were transfected with WT and mutant pMyc-CMV1-huTLR4 plasmids (2.5 μg/well each) or with pMyc-CMV1 mock plasmids using PLUS Reagent and Lipofectamine LTX Reagent (Life Technologies) for 24 h. The next day, cells were trypsinized and reseeded into cell culture plates for 48 h prior to LPS challenge. REFERENCES 1. Chen TL, Chen S, Wu HW, Lee TC, Lu YZ, Wu LL, et al. Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice. Gut Pathog. 2013;5(1):26. 2. Yu LC, Shih YA, Wu LL, Lin YD, Kuo WT, Peng WH, et al. Enteric dysbiosis promotes antibiotic-resistant bacterial infection: systemic dissemination of resistant and commensal bacteria through epithelial transcytosis. Am J Physiol Gastrointest Liver Physiol. 2014;307(8):G824-35. 3. Wu LL, Peng WH, Kuo WT, Huang CY, Ni YH, Lu KS, et al. Commensal Bacterial Endocytosis in Epithelial Cells Is Dependent on Myosin Light Chain Kinase-Activated Brush Border Fanning by Interferon-gamma. Am J Pathol. 2014;184(8):2260-74. 4. Huang CY, Kuo WT, Huang YC, Lee TC, Yu LC. Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells. Cell Death Dis. 2013;4:e622. 5. Wu LL, Chiu HD, Peng WH, Lin BR, Lu KS, Lu YZ, et al. Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C zeta. Crit Care Med. 2011;39:2087-98. 6. Yu LC, Turner JR, Buret AG. LPS/CD14 activation triggers SGLT-1-mediated glucose uptake and cell rescue in intestinal epithelial cells via early apoptotic signals upstream of caspase-3. Exp Cell Res. 2006;312(17):3276-86. 7. Yu LC, Flynn AN, Turner JR, Buret AG. SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? FASEB J. 2005;19(13):1822-35. 8. Yoo HH, Son J, Kim DH. Liquid chromatography-tandem mass spectrometric determination of ceramides and related lipid species in cellular extracts. J chromatograph. 2006;843(2):327-33.